Physician profile
Jay H Stone
NPI 1710961024
$65,930.72
in general payments reported to CMS, 2019-2025
50 companies · $851 in 2025
The $851 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,892 · 2020: $14K · 2021: $17K · 2022: $15K · 2023: $6,673 · 2024: $5,309 · 2025: $851.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,800 · Food and Beverage: $4,375 · Consulting Fee: $600 · Education: $32.27 · Travel and Lodging: $25.46.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,800.00 |
| Food and Beverage | $4,374.81 |
| Consulting Fee | $600.00 |
| Education | $32.27 |
| Travel and Lodging | $25.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $35,123.26 | 2019-2025 | Farxiga, Brilinta, Andexxa |
| E.R. Squibb & Sons, L.L.C. | $21,230.22 | 2019-2024 | Eliquis, Camzyos |
| Boston Scientific Corporation | $1,305.63 | 2019-2025 | Avvigo Guidance System, Lux-Dx Insertable Cardiac Monitor, Watchman Flx |
| Novartis Pharmaceuticals Corporation | $942.51 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $713.42 | 2019-2025 | Lifevest |
| Amgen INC. | $622.76 | 2019-2025 | Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $583.68 | 2019-2022 | |
| Medtronic, INC. | $521.39 | 2021-2024 | Hawkone, Onyx Frontier |
| Pfizer INC. | $518.13 | 2019-2025 | |
| Shockwave Medical, INC | $488.06 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Amarin Pharma, INC. | $368.69 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $322.31 | 2021-2025 | Verquvo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $298.90 | 2019-2024 | Jardiance |
| Novo Nordisk INC | $286.97 | 2021-2024 | Ozempic, Rybelsus |
| Abbott Laboratories | $259.81 | 2019-2025 | Aveir, Amplatzer Amulet, Jeti Peripheral Catheter |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endologix LLC | $257.54 | 2020-2025 | Torus Stent Graft System, Endocross Device |
| Cordis US Corp. | $244.88 | 2021-2024 | Mynx Control, Brite Tip Radianz |
| Medtronic Vascular, INC. | $205.72 | 2019-2020 | |
| Irhythm Technologies, INC. | $203.06 | 2022-2024 | Zio Xt Patch, Zio Monitor |
| Abiomed | $178.70 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $175.26 | 2019-2023 | |
| Avinger INC. | $171.07 | 2022-2023 | Pantheris |
| Philips North America LLC | $61.90 | 2024-2025 | (5044) Mcot, Mcot |
| Actelion Pharmaceuticals US, INC. | $59.64 | 2019-2025 | Opsumit, Uptravi |
| Cardiovascular Systems INC. | $59.07 | 2019-2020 | |
| Alnylam Pharmaceuticals INC. | $56.64 | 2025 | Onpattro |
| Gilead Sciences, INC. | $56.43 | 2019 | |
| Kiniksa Pharmaceuticals, LTD. | $56.05 | 2021-2023 | Arcalyst |
| Heartflow, INC. | $47.54 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $42.26 | 2019-2022 | |
| Kowa Pharmaceuticals America, INC. | $42.16 | 2019-2021 | |
| Arbor Pharmaceuticals, INC. | $42.09 | 2019-2021 | |
| Edwards Lifesciences Corporation | $41.19 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Penumbra, INC. | $41.09 | 2019-2024 | Indigo System |
| Terumo Medical Corporation | $38.54 | 2019-2024 | Metacross Otw, Glidewire |
| Astellas Pharma US INC | $28.50 | 2019-2020 | |
| Lexicon Pharmaceuticals, INC. | $26.91 | 2023 | Inpefa |
| Itamar Medical INC | $20.74 | 2022 | |
| Cvrx, INC. | $20.06 | 2024 | Barostim Neo System |
| Angiodynamics, INC. | $18.20 | 2022 | |
| Kestra Medical Technology Services, INC. | $17.18 | 2024 | Assure Wcd |
| Scpharmaceuticals INC. | $16.58 | 2023 | |
| Azurity Pharmaceuticals, INC. | $15.83 | 2023 | Edarbi |
| Bardy Diagnostics, INC. | $15.00 | 2021 | |
| Esperion Therapeutics, INC. | $14.71 | 2020 | |
| Teleflex LLC | $14.44 | 2019 | |
| Portola Pharmaceuticals, LLC | $14.35 | 2019 | |
| Chiesi USA, INC. | $14.27 | 2019 | |
| Bridgebio Pharma, INC. | $14.26 | 2025 | Attruby |
| G Medical Diagnostic Services, INC. | $13.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Stone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.